Chemed (CHE): Forward P/E Multiple

Official company branding of Chemed Corporation (CHE)

Chemed Corporation (CHE) maintains stability through a balance of medical empathy and rigorous service KPIs. Revenues are supported by Medicare government funding, an aging population, and consumer household spending. Hospice occupancy rates and demand for plumbing supplies provide a reliable foundation. The trend is confirmed by the company's forward P/E ratio dynamics, where 19.60 represents the current value of the metric.

CHE - Roto-Rooter Price to Future Earnings Ratio over the range 07/04/2022 - 11/15/2026

Metric breakdowns and analytics for chemed.com (CHE)

- stock value and consensus price forecast:
Analysis of all company metrics:CHE VITAS Healthcare
Brand item of Chemed Corporation

Chemed Corporation (CHE) operates in the heavily regulated palliative care sector, where market access is restricted by the complexity of obtaining federal Medicare licenses. The company's forward P/E ratio relates the current share price to expected net income, allowing investors to assess the premium paid for the asset and the dynamics of discounted cash flows under strict administrative control.